Dazed (MEDH) Stock Price, News & Analysis

Company Overview

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.

Key Stats

• Today's Range: $0.0006 to $0.0006
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0023
• Volume: 10,200 shs
• Average Volume: 1.40 million shs
• Market Capitalization: $414,299.40
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MEDH Stock Analysis - Frequently Asked Questions

How have MEDH shares performed this year?

Dazed's stock was trading at $0.0014 on January 1st, 2025. Since then, MEDH shares have decreased by 57.1% and is now trading at $0.0006.
View the best growth stocks for 2025 here.

How were Dazed's earnings last quarter?

Dazed, Inc. (OTCMKTS:MEDH) announced its quarterly earnings results on Tuesday, April, 1st. The company reported ($0.01) earnings per share for the quarter. The firm earned $0.33 million during the quarter.

How do I buy shares of Dazed?

Shares of MEDH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Dazed own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Dazed investors own include Healthier Choices Management (HCMC), Chevron (CVX), Clean Energy Technologies (CETY), Cerebain Biotech (CBBT), Refined Metals (CADMF), BancorpSouth Bank (BXS) and Blue Sphere (BLSP).

Company Calendar

• Last Earnings: 4/01/2025
• Today: 4/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Business services, not elsewhere classified
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:MEDH
• CIK: N/A
• Web: www.medxpharmaceuticals.com
• Phone: (612) 615-9334
• Fax: 720-407-6531
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-370,000.00
• Net Margins: -55.24%
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $450,000.00
• Price / Sales: 0.92
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 690,499,000
• Free Float: N/A
• Market Cap: $414,299.40
• Optionable: Not Optionable
• Beta: 3.28